Preoperative CEA and TAG-72 serum levels as prognostic indicators in resectable gastric carcinoma

International Journal of Biological Markers

Volumn 11, Issue 3, 1996, Pages 165-171

  Gonzalez A ^a   Vizoso, F ^b   Allende, M T ^c   Sanchez M T ^b   Balibrea, J L ^d   Ruibal, A ^c  

^a HOSPITAL GENERAL DE SEGOVIA   (Spain)

^b Research Unit Foundation Hospital of Jove   (Spain)

^c HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS   (Spain)

^d HOSPITAL CLÍNICO SAN CARLOS   (Spain)

Author keywords

CEA; Gastric cancer; TAG 72; Tumor markers

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; GLYCOPROTEIN; TUMOR ANTIGEN;

ADULT; AGED; ARTICLE; CANCER STAGING; CANCER SURGERY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PREOPERATIVE EVALUATION; STOMACH CANCER; STOMACH CARCINOMA;

EID: 0029829864     PISSN: 03936155     EISSN: None     Source Type: Journal    
DOI: 10.1177/172460089601100305     Document Type: Article

References (26)

1. Parkin MD, Stjernsward J, Muir C. Estimates of the worldwide frequency of twelve major cancers. Int J Cancer 1988; 41: 184-97.
2. Correa P. Human gastric carcinogenesis: a multistep and multifactorial process. First American Cancer Society Award Lecture on Cancer Epidemiology and Prevention. Cancer Res 1992; 52: 6735-40.
3. Wanebo HJ, Rao B, Pinsky CM, et al. Preoperative carcinoembryonic antigen level as a prognostic indicator in colorectal cancer. N Engl J Med 1978; 299: 448-51.
4. Wolmark N, Fisher B, Wieand S, Henry RS. The prognostic significance of preoperative carcinoembryonic antigen levels in colorectal cancer. Ann Surg 1984; 199: 375-81.
5. Filella X, Molina R, Grau JJ, et al. Prognostic value of CA 19.9 levels in colorectal cancer. Ann Surg 1991; 216: 55-9.
6. Yasue M, Sakamoto J, Teramukai S, et al. Prognostic values of preoperative and postoperative CEA and CA 19.9 levels in pancreatic cancer. Pancreas 1994; 9: 735-40.
7. Berruti A, Tampellini M, Torta M, Buniva T. Gorzegno G, Dogliotti L. Prognostic value in predicting overall survival of two mucinous markers: CA 15-3 and CA 125 in breast cancer patients at first relapse of disease. Eur J Cancer 1994; 30A: 2082-4.
8. Nagele F, Petru E, Medl M, Kainz C, Graf AH, Sevelda P. Preoperative CA 125: an independent prognostic factor in patients with stage I epithelial ovarian cancer. Obstet Gynecol 1995; 98: 259-64.
9. Muti M, Teramoto YA, Mariani-Constantin E, Horan Hand P, Colcher D, Schlom J. A monoclonal antibody (B72.3) defines patterns of novel Tumor Associated Antigen in human mammary carcinoma cell populations. Int J Cancer 1982; 29: 539-45.
10. Johnson VG, Schlom J, Paterson AJ, Bennet J, Magnani JL, Colcher D. Analysis of human Tumor-Associated Glycoprotein (TAG-72) identified by monoclonal antibody B72.3. Cancer Res 1986; 46: 850-7.
11. Klug TL, Sattler MA, Colcher D, Schlom J. Monoclonal antibody immunoradiometric assay for an antigenic determinant (CA 72) on a novel pancarcinoma antigen (TAG-72). Int J Cancer 1986; 38: 661-9.
12. Colcher D, Horan Hand P, Nuti M, Schlom J. A spectrum of monoclonal antibodies reactive with human mammary tumor cells. Proc Natl Acad Sci USA 1981; 78: 3119-203.
13. Heptner G, Domschke S, Domschke W. Comparison of CA 72-4 with CA 19-9 in the serodiagnostics of gastrointestinal malignancies. Scand J Gastroenterol 1989; 24: 745-50.
14. Filella X, Fuster J, Molina R, et al. TAG-72, CA 19.9 and CEA as tumor markers in gastric cancer. Acta Oncological 1994; 33: 747-51.
15. Joypaul B, Browning M, Newman E, Byrne D, Cuschieri A. Comparison of serum CA 72-4 and CA 19-9 levels in gastric cancer patients and correlation with recurrence. Am J Surg 1995; 169: 595-9.
16. Hermanek P, Sobin LJ, editors. UICC TNM classification of malignant tumors. 4th ed. 2nd rev. Berlin: Springer, 1992.
17. Gonzalez A, Allende MT, Vizoso F, Ruibal A. Comportamiento de la glucoproteína asociada a tumores (TAG-72), definida por el monoclonal B72.3 en el suero de pacientes con patologías no tumorales. Rev Clin Esp 1990; 186: 362-3.
18. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 457-81.
19. Mantel N, Myers M. Problems of convergence of maximum likehood iterative procedures in multiparameter situations. J Am Statis Assoc 1971; 66: 484-91.
20. Cox DR. Regression models and life tables. J R Statist Soc B 1972; 34: 187-220.
21. Dixon WJ, ed. BMDP statistical software. Release 1990. Berkeley: University of California Press, 1986.
22. Shimizu N, Wakatsuki T, Murakami A, et al. Carcinoembryonic antigen in gastric cancer patients. Oncology 1987; 44: 240-4.
23. Staab HJ, Anderer FA, Brummendorf T, Stumpf E, Fischer R. Prognostic value of preoperative serum CEA level compared to clinical staging: II. Stomach cancer. Br J Cancer 1982; 45: 718-27.
24. Steele G, Ellenberg S, Ramming K, et al. CEA monitoring among patients in multiinstitutional adjuvant GI therapy protocols. Ann Surg 1982; 196: 162-9.
25. Posner MR, Mayer RJ. The use of serologic tumor markers in gastrointestinal malignancies. Hematol Oncol Clin North Am 1994; 8: 533-53.
26. Ohuchi N, Takahashi K, Motoba N, et al. Comparison of serum assay for TAG-72, CA 19-9, and CEA in gastrointestinal carcinoma patients. Jpn J Clin Oncol 1989; 19: 242-8.